Sanibel Captiva Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.5M Buy
36,471
+2,749
+8% +$2.79M 0.94% 29
2025
Q4
$36.2M Buy
33,722
+3,566
+12% +$3.41M 1% 24
2025
Q3
$23M Buy
30,156
+2,589
+9% +$1.93M 0.66% 39
2025
Q2
$21.5M Buy
27,567
+841
+3% +$654K 0.66% 38
2025
Q1
$22.1M Buy
26,726
+2,561
+11% +$2.13M 0.72% 37
2024
Q4
$18.7M Buy
24,165
+4,065
+20% +$3.37M 0.6% 43
2024
Q3
$17.8M Sell
20,100
-166
-0.8% -$149K 0.57% 48
2024
Q2
$18.3M Buy
20,266
+54
+0.3% +$43.2K 0.63% 44
2024
Q1
$15.7M Sell
20,212
-42
-0.2% -$29.9K 0.54% 53
2023
Q4
$11.8M Buy
+20,254
New +$11.8M 0.44% 62

Other funds holding LLY

Sanibel Captiva Trust Company's LLY Position: Q1 2026 in Review

Sanibel Captiva Trust Company increased its Eli Lilly (LLY) stake by 8.2% in Q1 2026, buying an estimated $2.79M and bringing the position to 36,471 shares worth $33.5M. The position accounts for 0.94% of the portfolio, ranked #29.

Sanibel Captiva Trust Company first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $36.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sanibel Captiva Trust Company held 36,471 shares of Eli Lilly worth $33.5M as of Q1 2026.
  • Sanibel Captiva Trust Company bought 2,749 Eli Lilly shares in Q1 2026, an estimated $2.79M.
  • Eli Lilly made up 0.94% of Sanibel Captiva Trust Company's portfolio in Q1 2026, its #29 holding.
  • Sanibel Captiva Trust Company first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Sanibel Captiva Trust Company's Eli Lilly position peaked at $36.2M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q1 2026, filed 15 May 2026.